
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AKT as a Therapeutic Target for Cancer
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 646
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 646
Showing 1-25 of 646 citing articles:
PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
Hui‐Zhi Long, Yan Cheng, Ziwei Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 293
Hui‐Zhi Long, Yan Cheng, Ziwei Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 293
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 225
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 225
Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy
Faustino Mollinedo, Consuelo Gajate
Journal of Lipid Research (2020) Vol. 61, Iss. 5, pp. 611-635
Open Access | Times Cited: 198
Faustino Mollinedo, Consuelo Gajate
Journal of Lipid Research (2020) Vol. 61, Iss. 5, pp. 611-635
Open Access | Times Cited: 198
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
Federica Martorana, Gianmarco Motta, Giuliana Pavone, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 173
Federica Martorana, Gianmarco Motta, Giuliana Pavone, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 173
Targeting Akt in cancer for precision therapy
Hui Hua, Hongying Zhang, Jingzhu Chen, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 157
Hui Hua, Hongying Zhang, Jingzhu Chen, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 157
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
Victoria Callahan, Seth A. Hawks, Matthew A. Crawford, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 118
Victoria Callahan, Seth A. Hawks, Matthew A. Crawford, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 118
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Yundong He, Weidong Xu, Yu‐Tian Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 117
Yundong He, Weidong Xu, Yu‐Tian Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 117
The Hallmarks of Flavonoids in Cancer
Luis Gustavo Saboia Ponte, Isadora Carolina Betim Pavan, Mariana Camargo Silva Mancini, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 2029-2029
Open Access | Times Cited: 113
Luis Gustavo Saboia Ponte, Isadora Carolina Betim Pavan, Mariana Camargo Silva Mancini, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 2029-2029
Open Access | Times Cited: 113
PI3K/Akt/mTOR signaling pathway in cancer stem cells
Mohsen Karami Fath, Menooa Ebrahimi, Ehsan Nourbakhsh, et al.
Pathology - Research and Practice (2022) Vol. 237, pp. 154010-154010
Closed Access | Times Cited: 90
Mohsen Karami Fath, Menooa Ebrahimi, Ehsan Nourbakhsh, et al.
Pathology - Research and Practice (2022) Vol. 237, pp. 154010-154010
Closed Access | Times Cited: 90
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1231-1231
Open Access | Times Cited: 75
Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1231-1231
Open Access | Times Cited: 75
Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103749-103749
Closed Access | Times Cited: 75
Motahareh Mortazavi, Fatemeh Moosavi, Miriam Martini, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103749-103749
Closed Access | Times Cited: 75
A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage
Yujie Zhang, Jingjie Zhao, Lingmin Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101798-101798
Closed Access | Times Cited: 57
Yujie Zhang, Jingjie Zhao, Lingmin Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101798-101798
Closed Access | Times Cited: 57
Targeting Breast Cancer: An Overlook on Current Strategies
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 39
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 39
Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent
Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 126-126
Open Access | Times Cited: 17
Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 126-126
Open Access | Times Cited: 17
Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
Hua Su, Chao Peng, Yang Liu
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 16
Hua Su, Chao Peng, Yang Liu
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 16
2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis
Peng Fu, Minru Liao, Wenke Jin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Peng Fu, Minru Liao, Wenke Jin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation
Han Tian, Rong Lian, Yun Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 101
Han Tian, Rong Lian, Yun Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 101
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
Borja Guerra, Carlota Recio, Haidée Aranda-Tavío, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 94
Borja Guerra, Carlota Recio, Haidée Aranda-Tavío, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 94
Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer
Sameera Nallanthighal, James Patrick Heiserman, Dong‐Joo Cheon
Cancers (2021) Vol. 13, Iss. 5, pp. 935-935
Open Access | Times Cited: 83
Sameera Nallanthighal, James Patrick Heiserman, Dong‐Joo Cheon
Cancers (2021) Vol. 13, Iss. 5, pp. 935-935
Open Access | Times Cited: 83
Andrographolide and its derivatives: Current achievements and future perspectives
Hang Zhang, Shufeng Li, Yongsheng Si, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113710-113710
Closed Access | Times Cited: 81
Hang Zhang, Shufeng Li, Yongsheng Si, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113710-113710
Closed Access | Times Cited: 81
LncRNA AFAP1-AS1 Supresses miR-139-5p and Promotes Cell Proliferation and Chemotherapy Resistance of Non-small Cell Lung Cancer by Competitively Upregulating RRM2
Na Huang, Wei Guo, Ke Ren, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 80
Na Huang, Wei Guo, Ke Ren, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 80
Antitumor Effects of Carvacrol and Thymol: A Systematic Review
Laeza Alves Sampaio, Lícia Tairiny Santos Pina, Mairim Russo Serafini, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 78
Laeza Alves Sampaio, Lícia Tairiny Santos Pina, Mairim Russo Serafini, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 78
Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
Seyede Nazanin Zarneshan, Sajad Fakhri, Mohammad Hosein Farzaei, et al.
Food and Chemical Toxicology (2020) Vol. 145, pp. 111714-111714
Closed Access | Times Cited: 77
Seyede Nazanin Zarneshan, Sajad Fakhri, Mohammad Hosein Farzaei, et al.
Food and Chemical Toxicology (2020) Vol. 145, pp. 111714-111714
Closed Access | Times Cited: 77
The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
Terézia Kisková, Peter Kubatka, Dietrich Büsselberg, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 161-161
Open Access | Times Cited: 72
Terézia Kisková, Peter Kubatka, Dietrich Büsselberg, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 161-161
Open Access | Times Cited: 72
Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis
Borui Li, Yi Qin, Xianjun Yu, et al.
Cell Proliferation (2021) Vol. 55, Iss. 1
Open Access | Times Cited: 59
Borui Li, Yi Qin, Xianjun Yu, et al.
Cell Proliferation (2021) Vol. 55, Iss. 1
Open Access | Times Cited: 59